AlphAIAlphAI — Financial news for AI agents
SEC EDGAR 8-KNOV 32 min read$SLRC

SLR Investment Corp. Announces Quarter Ended September 30, 2026 Financial Results

SLR Investment Corp. (SLRC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 SLR Investment Corp. Announces Quarter Ended September 30, 2026 Financial Results Net Investment Income of $0.33 Per Share for Q3 2026; Declared Quarterly Distribution of $0.31 Per Share NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- SLR Investment Corp. (NASDAQ: SLRC)

Original reporting
SEC EDGAR 8-K
Published Nov 3, 2026, 10:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 10:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$SLRC
Neutral
high confidence
Mentioned
$SLRC
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SLRCNeutralHigh
01

Why it matters

The disclosed numbers confirm the company's ability to meet its distribution, suggesting stability but limited growth momentum.

02

Market read

Primary earnings disclosure for a niche finance vehicle; relevant for dividend‑seeking investors and specialty finance analysts.

03

What to watch

The low watchlist exposure (2% of portfolio) and minimal software exposure could support a defensive stance despite modest growth.

Relevance 7/10Novelty 7/10Timing: post‑market today

Background

SLR Investment Corp. is a specialty finance BDC listed on NASDAQ, reporting quarterly results via a Form 8‑K filing.

Company-level read

Ticker impact

$SLRCNeutralHigh confidence
Context

SEC 8‑K disclosed Q3 2026 net investment income of $0.33 per share and a $0.31 quarterly distribution, the first public release of these results.

Expected impact

likely modest upside or flat as investors price in the covered distribution and stable NAV.

Evidence & confidence

The earnings beat expectations only marginally and the distribution is fully covered, so price reaction should be limited.

Market effects

Sector

Provides a data point on specialty finance portfolio performance in a higher‑for‑longer rate environment.

Regional

Limited to investors in niche finance and dividend‑focused funds.

Global

Low; the filing does not affect broader market trends.

Counterpoint

What could challenge this read

If investors expect higher yields from specialty finance, the flat NII may be seen as a weakness, prompting a short bias.

Key entities

  • Executive
    Michael Gross

    Co‑CEO who commented on the portfolio's positioning in a higher‑for‑longer rate environment.

  • Executive
    Bruce Spohler

    Co‑CEO who highlighted watchlist exposure and portfolio quality.

Read at source← All news

Related articles

AUG 4
$SLRCMed

SLR Investment Corp. Announces Quarter Ended June 30, 2026 Financial Results

SLR Investment Corp. (SLRC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 SLR Investment Corp. Announces Quarter Ended June 30, 2026 Financial Results Net Investment Income of $0.33 Per Share for Q2 2026; Declared Quarterly Distribution of $0.31 Per Share NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- SLR Investment Corp. (NASDAQ: SLRC) (the

SEC EDGAR 8-K3 min
NOV 4
$SOPHMed

Sophia Genetics SA (SOPH) (Q3 2026) Earnings Call Highlights: Revenue Surges 25% with Strong

Sophia Genetics SA (SOPH) reported a 25% revenue surge in Q3 2026. CEO Ross Muken expects continued growth in 2027, driven by strong product momentum and a high backlog of customers. The company is investing in medical affairs to drive adoption and has secured notable biopharma collaborations, including with AstraZeneca. CFO George Cardoza emphasized profitability commitments and conservative guidance.

finance.yahoo.com7 min
NOV 4
$AEHRHighAI 9/10

Aehr Test Systems (AEHR) (Q1 2027) Earnings Call Highlights: Record Revenue, Raised

Aehr Test Systems (AEHR) reported record Q1 2027 revenue of $33M and raised annual guidance to $150M. CEO Gayn Erickson highlighted a potential large burn-in opportunity, estimating $35M-$70M in revenue per million units shipped. The company expects sequential growth in remaining quarters, with Q4 potentially the highest. Management confirmed they are not supply-constrained and can ship more than guided. Silicon carbide revenue was about $10M in fiscal 2026, with expectations for growth in 2027.

finance.yahoo.com7 min
NOV 4
$HLFMedAI 8/10

Herbalife Ltd (HLF) (Q3 2026) Earnings Call Highlights: Fifth Straight Quarter

Herbalife (HLF) reported Q3 2026 net sales of $1.4B, up 6% YoY, and adjusted EBITDA of $182M, beating guidance. Growth was driven by India and nutrition clubs, while EMEA and China saw declines. The company raised full-year sales guidance but expects gradual margin expansion. Interim CEO John DeSimone discussed product repositioning and new technology platforms. Operating cash flow rose 27% YoY, and net leverage improved to 2.0x.

finance.yahoo.com7 min
NOV 4
$SBACMed

SBA Communications Corp (SBAC) Q3 2026 Earnings Call Highlights: Strong Margins

SBA Communications (SBAC) reported Q3 2026 earnings with strong margins (80% tower cash flow, 69% adjusted EBITDA) and returned $430M to shareholders. The company raised its dividend by 13% and maintains a solid balance sheet. It is exiting non-core markets and focusing on growth regions. Challenges include elevated churn and a 2027 debt refinancing wall. Management expects sustained leasing growth from spectrum auctions and sees potential in edge computing.

finance.yahoo.com7 min